How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Area of Science:

• Cardiovascular Research
• Metabolic Syndrome Research
• Inflammation Biology

Background:

• Elevated triglyceride (TG) and low high-density-lipoprotein cholesterol (HDL-C) are key features of metabolic syndrome and type 2 diabetes.
• These lipid abnormalities are linked to increased inflammation and atherosclerosis, posing significant cardiovascular risk.

Purpose of the Study:

• To review current research on the mechanisms by which high TG and low HDL-C contribute to inflammation and atherosclerosis.
• To highlight the predictive value of TG-rich lipoproteins and the importance of HDL functionality in cardiovascular disease (CAD).

Main Methods:

• Literature review of recent research studies.
• Analysis of evidence linking TG-rich lipoproteins, apolipoproteins, and inflammatory pathways.
• Examination of HDL's cardioprotective functions beyond reverse cholesterol transport.

Main Results:

• TG-rich lipoproteins, via apolipoproteins and free fatty acids, activate inflammatory mediators (NFKβ, VCAM-1), promoting atherosclerosis.
• Cholesterol content in TG-rich lipoproteins may be a better predictor of CAD risk than LDL-C.
• HDL functionality, not just HDL-C levels, is crucial for cardioprotection and immune regulation.

Conclusions:

• Insulin resistance and obesity are central to the pathophysiology of high TG and low HDL-C.
• Lifestyle interventions, including exercise and weight loss, are primary therapies for improving insulin resistance and mitigating adverse lipid-driven inflammatory processes.